Noxafil and Malabsorption - a phase IV clinical study of FDA data

Summary:

Malabsorption is reported as a side effect among people who take Noxafil (posaconazole), especially for people who are female, 0-1 old, have been taking the drug for 2 - 5 years also take Famotidine, and have Mucormycosis.

The phase IV clinical study analyzes which people have Malabsorption when taking Noxafil. It is created by eHealthMe based on reports of 5,902 people who have side effects when taking Noxafil from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Malabsorption?

Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract) is found to be associated with 753 drugs and 1,080 conditions by eHealthMe. Check the latest studies of Malabsorption.

On Oct, 15, 2025

5,902 people reported to have side effects when taking Noxafil.
Among them, 9 people (0.15%) have Malabsorption.

Among these 9 people:

How long have people been on Noxafil when they have Malabsorption? *

What is the gender of people who have Malabsorption when taking Noxafil? *

female: 100 %
male: 0.0 %

What is the age of people who have Malabsorption when taking Noxafil? *

What are other drugs people take besides Noxafil? *

What are other side effects people have besides Malabsorption? *

Nausea And Vomiting: 2 people, 22.22%
Nausea (feeling of having an urge to vomit): 2 people, 22.22%
Overdose: 2 people, 22.22%
Pulmonary Haemosiderosis (recurrent lungs bleeding): 1 person, 11.11%
Duodenal Stenosis (block of the first part of the small intestine): 1 person, 11.11%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 11.11%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 1 person, 11.11%
Cardiac Failure Congestive: 1 person, 11.11%
Drug Effect Decreased: 1 person, 11.11%
Drug Ineffective: 1 person, 11.11%

What are the existing conditions these people have? *

Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 5 people, 55.56%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and have Malabsorption?

- Check whether Malabsorption is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Noxafil:

Noxafil (5,919 reports)

Malabsorption treatments and more:

Malabsorption (8,910 reports)

Browse all side effects of Noxafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malabsorption:

Malabsorption (753 drugs)

Browse all the conditions that are associated with Malabsorption:

Malabsorption (1,080 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole (the active ingredients of Noxafil) and Noxafil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.